Exploring the interplay between Alzheimer's disease and COVID-19: Insights into cognitive impairment and drug interactions

Abstract

Alzheimers disease (AD) is a severe well-known cognitive disease, and it is also the most worldwide cause of dementia. Studies have shown that AD may have some interactions with the coronavirus disease 2019 (COVID-19) in some particular areas. This paper aims to figure out the potential associations how one causes the interplay of another, whether directly or indirectly. In addition, the paper provides a comprehensive mechanism underlying cognitive impairment also known as brain fog of COVID-19, including the effects on neurons and glial cells by persistent elevation of the chemokine CCL11. Then the paper provides drug-drug interaction with metabolized by same cytochrome enzymes lead to major changes in the pharmacology of treatments. Finally, the paper concludes the points mentioned about the associations between COVID-19 and AD then suggests the direction of the future studies.